ID26327A - LOW COMPOSITION OF MYCOBACTERIUM VACCAE AND METHODS FOR ITS USE - Google Patents

LOW COMPOSITION OF MYCOBACTERIUM VACCAE AND METHODS FOR ITS USE

Info

Publication number
ID26327A
ID26327A IDW20001433A ID20001433A ID26327A ID 26327 A ID26327 A ID 26327A ID W20001433 A IDW20001433 A ID W20001433A ID 20001433 A ID20001433 A ID 20001433A ID 26327 A ID26327 A ID 26327A
Authority
ID
Indonesia
Prior art keywords
methods
mycobacterium vaccae
low composition
composition
low
Prior art date
Application number
IDW20001433A
Other languages
Indonesian (id)
Inventor
Tan Paul
Watson James
Elizabeth S Visser
Margot A Skinner
Ross L Prestidge
Original Assignee
Genesis Res & Dev Corp Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/997,080 external-priority patent/US5968524A/en
Priority claimed from US08/997,362 external-priority patent/US5985287A/en
Priority claimed from US09/095,855 external-priority patent/US6160093A/en
Priority claimed from US09/205,426 external-priority patent/US6406704B1/en
Application filed by Genesis Res & Dev Corp Ltd filed Critical Genesis Res & Dev Corp Ltd
Publication of ID26327A publication Critical patent/ID26327A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/04Mycobacterium, e.g. Mycobacterium tuberculosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/06Antibacterial agents for tuberculosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IDW20001433A 1997-12-23 1998-12-23 LOW COMPOSITION OF MYCOBACTERIUM VACCAE AND METHODS FOR ITS USE ID26327A (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US99662497A 1997-12-23 1997-12-23
US08/997,080 US5968524A (en) 1997-12-23 1997-12-23 Methods and compounds for the treatment of immunologically-mediated psoriasis
US08/997,362 US5985287A (en) 1996-08-29 1997-12-23 Compounds and methods for treatment and diagnosis of mycobacterial infections
US09/095,855 US6160093A (en) 1996-08-29 1998-06-11 Compounds and methods for treatment and diagnosis of mycobacterial infections
US15618198A 1998-09-17 1998-09-17
US09/205,426 US6406704B1 (en) 1996-08-29 1998-12-04 Compounds and methods for treatment and diagnosis of mycobacterial infections

Publications (1)

Publication Number Publication Date
ID26327A true ID26327A (en) 2000-12-14

Family

ID=27557521

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20001433A ID26327A (en) 1997-12-23 1998-12-23 LOW COMPOSITION OF MYCOBACTERIUM VACCAE AND METHODS FOR ITS USE

Country Status (15)

Country Link
EP (1) EP1044273A2 (en)
JP (1) JP2002514385A (en)
CN (1) CN1294632A (en)
AU (1) AU746311B2 (en)
BR (1) BR9814432A (en)
CA (1) CA2315539A1 (en)
HU (1) HUP0100352A2 (en)
ID (1) ID26327A (en)
IL (1) IL136821A0 (en)
MX (1) MXPA00006168A (en)
NO (1) NO20003261L (en)
NZ (1) NZ505834A (en)
PL (1) PL341697A1 (en)
TR (1) TR200001948T2 (en)
WO (1) WO1999032634A2 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6569436B1 (en) 1998-10-05 2003-05-27 The Malaghan Institute Of Medical Research Method of using a vaccine
JP4415200B2 (en) * 1999-01-29 2010-02-17 大塚製薬株式会社 Late-growing mycobacterial polypeptide
GB9903539D0 (en) 1999-02-16 1999-04-07 Stanford Rook Ltd Therapy using M.Vaccae
US6350457B1 (en) * 1999-06-02 2002-02-26 Genesis Research & Development Corporation Limited Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae
WO2001004140A1 (en) * 1999-07-12 2001-01-18 Genesis Research & Development Corporation Limited Compounds for treatment of infectious and immune system disorders and methods for their use
JP2003508054A (en) * 1999-08-31 2003-03-04 ニーデルバイス,ミヒャエル Method for producing channel-forming protein
US7217554B2 (en) 1999-08-31 2007-05-15 Novozymes A/S Proteases and variants thereof
AU6820000A (en) * 1999-08-31 2001-03-26 Novozymes A/S Novel proteases and variants thereof
US6361776B1 (en) * 1999-12-06 2002-03-26 Genesis Research & Development Corp. Ltd. Compounds isolated from M. vaccae and their use in modulation of immune responses
AU2403901A (en) * 1999-12-28 2001-07-09 Ichiro Azuma Maturation-promoting agent for immature dendritic cells
AUPQ761200A0 (en) * 2000-05-19 2000-06-15 Hunter Immunology Limited Compositions and methods for treatment of mucosal infections
AU2002309857A1 (en) * 2001-05-11 2002-12-03 Corixa Corporation Vaccines for the treatment of autoimmune disease
US20030147861A1 (en) * 2001-07-26 2003-08-07 Genesis Research And Development Corporation Limited Compounds and methods for the modulation of immune responses
AU2002353366A1 (en) * 2001-12-10 2003-06-23 Bakulesh Mafatlal Khamar The process of manufacturing a pharmaceutical composition useful for management of cancer
GB0303507D0 (en) * 2003-02-14 2003-03-19 Novartis Ag Organic compounds
CN106103471B (en) * 2014-01-09 2020-01-07 特兰斯吉恩股份有限公司 Fusion of heterooligomeric mycobacterial antigens

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8919321D0 (en) * 1989-08-25 1989-10-11 Univ London Treatment of chronic inflammatory conditions
GB9203814D0 (en) * 1992-02-21 1992-04-08 Univ London Treatment of long term auto-immune conditions
US6284255B1 (en) * 1996-08-29 2001-09-04 Genesis Research & Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections

Also Published As

Publication number Publication date
IL136821A0 (en) 2001-06-14
NO20003261L (en) 2000-08-22
MXPA00006168A (en) 2005-02-24
WO1999032634A2 (en) 1999-07-01
CN1294632A (en) 2001-05-09
BR9814432A (en) 2000-10-10
TR200001948T2 (en) 2001-02-21
PL341697A1 (en) 2001-04-23
AU1893699A (en) 1999-07-12
NO20003261D0 (en) 2000-06-22
EP1044273A2 (en) 2000-10-18
WO1999032634A3 (en) 1999-12-02
HUP0100352A2 (en) 2001-06-28
JP2002514385A (en) 2002-05-21
NZ505834A (en) 2002-12-20
AU746311B2 (en) 2002-04-18
CA2315539A1 (en) 1999-07-01

Similar Documents

Publication Publication Date Title
ID22889A (en) ETHYLENA COOPOLYMER COMPOSITION AND ITS USE
ID27922A (en) PHARMACICAL COMPOSITION AND USE OF ANDROST-5-ENA-3β, 17β-DIOL
ID26327A (en) LOW COMPOSITION OF MYCOBACTERIUM VACCAE AND METHODS FOR ITS USE
ID26964A (en) COMPOSITION AND METHODS FOR SETTING UP LIMFOSIT ACTIVITIES
ID24196A (en) COMPOSITION AND USE
ID22957A (en) COMPOUND AND ITS USE
DE69831755D1 (en) OPTOACUSTIC CONSTANCES AND METHOD OF USE
ID19588A (en) ESTER AND HETEROSICLIC AMIDA
BR9702553A (en) Cosmetic composition and use
ID23575A (en) PIRAZOLOPIRIMIDINA-PIRAZOLOPIRIMIDINA AND PIRAZOLOTRIAZINA-PIRAZOLOTRIAZINA
ID28728A (en) COMPOSITION AND CREATION PROCESS
ID24470A (en) HAIR COLOR COMPOSITION AND ITS USE
BR9508677A (en) Copolymer made of the same preparation and organic composition
IL132146A0 (en) Composition for the detection of electrophilic gases and methods of use thereof
ID17373A (en) BINDERS AND DIAPERS USING THE TYPE OF BINDER
ID23985A (en) BATTERY AND THE METHOD OF MAKING IT
DE69712962T2 (en) Styrene-butadiene copolymer and rubber compound containing this copolymer
DE69723398T2 (en) POLYALKYLPHENOXYAMINOALCANES AND THE SUBSTANCE COMPOSITIONS CONTAINING THEM
ID22847A (en) ANTISEBUM COMPOSITION AND ANTIOXIDANT CONTAINING GUGULIPID AND ITS ALCOHOL FACTIONS
DE69919549D1 (en) OXYGEN ABSORBING COMPOSITION AND ITS APPLICATION METHOD
ID17199A (en) MICRO-ORGANISM OF THE HYDROCARBON DECREASE OF HALOGEN AND ITS USE
ID20056A (en) LUBRIC OIL, COMPOSITION LUBRIC OIL AND COMPOSITION OF OIL FUEL
ID21847A (en) COMPOSITION OF INSECTICIDE AND METHODS OF USE
ID23258A (en) WITHDRAWAL-DELIVERY AND METHODS
ID19392A (en) NAFTIL COMPOUNDS AND MIDDLE MATERIALS AND COMPOSITION AND USE METHODS